All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
BRAINSTORM CELL THERAPEUTICS INC.: Last Reported 3/31/2020

Business Address

1325 AVENUE OF AMERICAS
28TH FLOOR
NEW YORK, NY US 10019

Mailing Address

1325 AVENUE OF AMERICAS
28TH FLOOR
NEW YORK, NY US 10019
Phone Number: 201-488-0460 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015 9/30/2015 8/31/2015 6/30/2015 3/31/2015 12/31/2014 9/30/2014 6/30/2014 3/31/2014 12/31/2013 12/31/2012
Cash and Cash Equivalents $12,471,000.00 $536,000.00 $2,095,000.00 $1,126,000.00 $3,238,000.00 $942,000.00 $697,000.00 $2,262,000.00 $3,246,000.00 $2,483,000.00 $2,464,000.00 $5,784,000.00 $604,000.00 $547,000.00 $955,000.00 $944,000.00 $2,213,000.00 $428,000.00 $710,000.00 -- $1,301,000.00 $3,494,000.00 $4,251,000.00 $8,969,000.00 $11,328,000.00 $3,027,000.00 $3,503,000.00 $1,317,000.00
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $279,000.00 $432,000.00 $619,000.00 $917,000.00 $1,237,000.00 $1,197,000.00 $1,238,000.00 $1,160,000.00 $1,143,000.00 $1,195,000.00 $86,000.00 $230,000.00 $176,000.00 $148,000.00 $82,000.00 $67,000.00 $80,000.00 $74,000.00 -- -- -- -- $32,000.00 -- -- -- -- --
Total Current Assets $15,205,000.00 $3,360,000.00 $4,672,000.00 $5,535,000.00 $8,257,000.00 $10,270,000.00 $12,621,000.00 $19,563,000.00 $7,865,000.00 $9,623,000.00 $10,951,000.00 $7,682,000.00 $8,725,000.00 $10,444,000.00 $11,385,000.00 $12,813,000.00 $13,510,000.00 $16,788,000.00 $18,091,000.00 -- $20,061,000.00 $22,078,000.00 $9,578,000.00 -- -- -- $4,446,000.00 --
Property Plant and Equipement $918,000.00 $960,000.00 $664,000.00 $599,000.00 $611,000.00 $651,000.00 $564,000.00 $596,000.00 $412,000.00 $392,000.00 $358,000.00 $295,000.00 $281,000.00 $297,000.00 $312,000.00 $318,000.00 $281,000.00 $271,000.00 $268,000.00 -- $282,000.00 $290,000.00 $313,000.00 -- -- -- $258,000.00 --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $2,866,000.00 $3,174,000.00 $3,139,000.00 $3,329,000.00 $3,594,000.00 $958,000.00 $1,148,000.00 $1,457,000.00 $1,548,000.00 $1,800,000.00 $384,000.00 $319,000.00 $307,000.00 $322,000.00 $337,000.00 $341,000.00 $304,000.00 $292,000.00 -- -- -- -- $333,000.00 -- -- -- -- --
Total Assets $18,071,000.00 $6,534,000.00 $7,811,000.00 $8,864,000.00 $11,851,000.00 $11,228,000.00 $13,769,000.00 $21,020,000.00 $9,413,000.00 $11,423,000.00 $11,335,000.00 $8,001,000.00 $9,032,000.00 $10,766,000.00 $11,722,000.00 $13,154,000.00 $13,814,000.00 $17,080,000.00 $18,359,000.00 -- $20,363,000.00 $22,387,000.00 $9,911,000.00 -- -- -- $4,726,000.00 --
Accounts Payable $4,571,000.00 $14,677,000.00 $9,144,000.00 $8,765,000.00 $5,029,000.00 $4,548,000.00 $2,602,000.00 $4,182,000.00 $3,261,000.00 $1,424,000.00 $275,000.00 $227,000.00 $362,000.00 $345,000.00 $352,000.00 $355,000.00 $281,000.00 $1,169,000.00 $335,000.00 -- $755,000.00 $922,000.00 $1,542,000.00 -- -- -- $228,000.00 --
Accrued Liabilities $1,303,000.00 $1,000,000.00 $1,975,000.00 $1,020,000.00 $2,246,000.00 $1,042,000.00 $428,000.00 $1,471,000.00 $442,000.00 $817,000.00 $204,000.00 $114,000.00 $90,000.00 $152,000.00 $576,000.00 $652,000.00 $675,000.00 $1,500,000.00 $2,308,000.00 -- $1,505,000.00 $1,571,000.00 $1,347,000.00 -- -- -- $877,000.00 --
Total Current Liabilities $9,060,000.00 $18,757,000.00 $14,588,000.00 $13,380,000.00 $11,525,000.00 $6,212,000.00 $3,791,000.00 $8,147,000.00 $5,579,000.00 $5,543,000.00 -- -- -- $864,000.00 -- -- -- $2,952,000.00 $2,838,000.00 -- $2,526,000.00 $2,726,000.00 $3,236,000.00 -- -- -- $1,987,000.00 --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $134,389,000.00 $105,042,000.00 $102,796,000.00 $99,423,000.00 $98,325,000.00 $94,620,000.00 $94,199,000.00 $93,935,000.00 $86,196,000.00 $85,944,000.00 $85,535,000.00 $85,227,000.00 $85,140,000.00 $85,014,000.00 $85,015,000.00 $84,754,000.00 $84,492,000.00 $84,258,000.00 $84,265,000.00 -- $83,978,000.00 $83,537,000.00 $68,317,000.00 -- -- -- $55,138,000.00 --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-125,390,000.00 $-117,276,000.00 $-109,584,000.00 $-103,950,000.00 $-99,050,000.00 $-94,023,000.00 $-88,640,000.00 $-85,464,000.00 $-82,373,000.00 $-80,075,000.00 $-80,351,000.00 $-77,948,000.00 $-76,908,000.00 $-75,123,000.00 $-74,499,000.00 $-72,893,000.00 $-71,931,000.00 $-70,141,000.00 $-68,757,000.00 -- $-66,154,000.00 $-63,889,000.00 $-61,653,000.00 -- -- -- $-52,407,000.00 --
Total Stockholders' Equity $9,011,000.00 $-12,223,000.00 $-6,777,000.00 $-4,516,000.00 $326,000.00 $5,016,000.00 $9,978,000.00 $12,873,000.00 $3,834,000.00 $5,880,000.00 $5,195,000.00 $7,290,000.00 $8,243,000.00 $9,902,000.00 $10,527,000.00 $11,872,000.00 $12,572,000.00 $14,128,000.00 $15,521,000.00 -- $17,837,000.00 $19,661,000.00 $6,675,000.00 -- -- -- $2,739,000.00 $3,982,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $18,071,000.00 $6,534,000.00 $7,811,000.00 $8,864,000.00 $11,851,000.00 $11,228,000.00 $13,769,000.00 $21,020,000.00 $9,413,000.00 $11,423,000.00 $11,335,000.00 $8,001,000.00 $9,032,000.00 $10,766,000.00 $11,722,000.00 $13,154,000.00 $13,814,000.00 $17,080,000.00 $18,359,000.00 -- $20,363,000.00 $22,387,000.00 $9,911,000.00 -- -- -- $4,726,000.00 --

Statement of Operations

Date 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015 9/30/2015 8/31/2015 6/30/2015 3/31/2015 12/31/2014 9/30/2014 6/30/2014 3/31/2014 12/31/2013 12/31/2012
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $5,948,000.00 $17,204,000.00 $11,018,000.00 $7,010,000.00 $3,456,000.00 $8,293,000.00 $1,975,000.00 $1,481,000.00 $977,000.00 $977,000.00 $2,544,000.00 $1,376,000.00 $941,000.00 $2,250,000.00 $1,927,000.00 $1,137,000.00 $986,000.00 $4,949,000.00 $1,503,000.00 -- $1,375,000.00 $1,245,000.00 $4,772,000.00 $3,129,000.00 $1,557,000.00 $680,000.00 $2,917,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- $2,205,000.00 $7,421,000.00 -- -- $1,031,000.00 $5,043,000.00 --
Loss from Operations $-8,308,000.00 $-23,001,000.00 $-15,336,000.00 $-4,857,000.00 $-4,928,000.00 $-14,063,000.00 $-3,232,000.00 $-3,087,000.00 $-2,307,000.00 $-4,999,000.00 $-2,392,000.00 $-1,075,000.00 $-1,770,000.00 $-5,083,000.00 $-4,433,000.00 $-2,795,000.00 $-1,812,000.00 $-8,536,000.00 $-2,571,000.00 -- $-4,568,000.00 $-2,236,000.00 $-9,246,000.00 $-2,430,000.00 $-2,325,000.00 $-2,111,000.00 $-4,899,000.00 --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 800,000,000 800,000,000 800,000,000 -- -- -- 800,000,000 --
Common Stock Shares Outstanding 28,423,837 23,174,228 22,606,492 21,708,442 21,490,610 20,757,816 20,700,713 20,669,528 19,111,326 18,976,169 18,842,726 18,747,327 18,699,665 18,687,987 18,687,987 18,654,040 18,654,040 18,643,288 18,480,957 -- 18,480,957 18,393,546 15,281,497 -- -- -- 11,750,881 --
Copyright 2020 PursePoor.com